Member Info for Safy

Can someone please confirm that the Mologic Elisa test works on Saliva and NOT swab. According to the post above it says Saliva but I’m guessing this is a typo.

If it is Saliva this is HUGE news.

woooooot

199.99 a machine???, i somehow doubt it mate. If they cost that much ill donate 5 to CK right now.

AUAddicted

How much does a machine cost?

I think WHO might be on Friday this week or Monday next week, i vaguely recall checking this before for GDR.

The website gets updated today, but the approval itself lands earlier. I hope im wrong and it is today but if its not today it could be later in the week too.

THANKYOU VERY MUCH

I WAS JUST WONDERING WHETHER SOME POSTERS TOOK THE STUPID PILL LAST NIGHT BEFORE BED.

THEIR CONTRACT IS NOT FOR ANTIBODY TESTS.

Apologies for caps, hope it makes it clear enough x

Different test, they didn’t sign an antibody test contract

FSA

Our test and NCYT test is pretty much identical in performance.

Our test can be done at home!! There’s in a lab.

How can that be competition?

@Trilla

Slight correction, we may not be invested in Mologic, but their success adds significant value to ODX.

There are two tests in this world that are in huge demand. Antigen LFT first and then Antibody LFT. We have Antibody LFT covered with BOTH Mologic and ukrtc. Antigen LFT we need Mologic there. That test is more in demand than any other test in the WHOLE world.

So yes Mologic is huge for us.

ODX are a manufacturing company, under licence they could possibly produce these tests.

Nothing to worry about. Same way ODX are talking to AVCT. If anyone has a test, ODX can work with them.

ODX - a finger in every test

ODX have had initial discussions with Avacta but premature to say they will be working with them, If ODX sign anything thY will release a RNS.

This is the official line from ODX.

MB its irrelevant, we have NOT stopped any manufacturing to make space for what might come from AVCT.

How is that a bad thing?

are you serious?

AIM is mostly built on hope. Our current SP is built on hope, we have not manufactured a single test yet. We hope to start manufacturing tests next month, we hope to get the gov order, we hope to get MHRA.

So how could another hope be a bad thing.

Exactly SIMOD,

This further derisks us, the icing on the cake would be if AVCT succeed and we do end up making tests for them, the test has an ODX logo on it.

Im failing to understand why the negativity here. Bottom line is that manufacturing is largely automated. A few more machine can only be good for us.

If its true then we've just got another finger in a test, that derisks us more. Now we have two shots at the ultimate goal, which is the Antigen LFT. Mologic and AVCT.

We also have the skills and capability to manufacture LFT's, this makes us more attractive to companies looking to manufacture. Today it's AVCT, tomorrow it could be someone else.

Personally, its irrelevant how far AVCT are, as long as we can set up production lines, and increase capacity, its all money in the bank, we were aiming for 1m tests a week, you have to fill that up somehow and increase it. Colin isn't stupid, you go where the money is. This is NOT a bad deal for us. If AVCT manage to make a test, great, if they don't still great. Lots of options here.

ODX - A finger in every test.

@1509 and playingtheodds

My posts are my own views, but pls don’t risk your hard earned by reading a post. It’s always best to do your own research too. I’ve tried to be balanced here and credit is due to NCYT. There was a period when they were stuck at 270p, and not much was happening whilst other shares were rising. Now it’s their turn.

Bottom line the cream always rises to the top. The ****ty fake ceos of some of these aim covid stocks eventually get found out. I’m hoping ODX will be one of the good investments.

NCYT had a test which was as good as any at the time (not very good) but they were in a group which consisted of a handful that had a test which worked.

When they were applying for clearances it used to take 2-3 days for FDA. Now it takes 3-4 months plus political bias. So this gave them market advantage, they were there first and were first to market.

Since then, they have improved their tests significantly and obviously being first to market has meant they have the cash flow coming in and established sales channels.

Once a testing system has been configured to work with a particular test, there is little appetite to change. That’s where they have an advantage over others.

Their skills and expertise have allowed them to work on more covid products too.

However as this is an ODX board so it is prudent to know for the antibody LFT we are ahead of them. Miles ahead. And let’s not forget Mologic antigen LFT. Mologic are quite advanced there too.

LFT is the end game, pregnancy type tests. Of two possible tests we already have one, and this test also happens to be one of the best in the world. Next stop Mologic LFT...

ODX - fingers in all the tests

No, says partner lab.

We don’t need a lab

GP,

That looks like it’s straight from the abi white paper.

Dave77 when it hit 65p it was dark days. Very dark days.

Radio silence from GDR. Everyday it was tanking to new lows.

ihavenoclue

sorry mate, i think your waaay off the mark here. Kenbob left GDR a few months ago. He was having a panic attack daily seeing the SP tumble when we hit 65p so ended up selling out. He was a good guy.